According to a new report by Univdatos, the global acute respiratory distress syndrome (ARDS) market is expected to reach around USD 1,987  Million in 2032 by growing at a CAGR of 8%. ARDS can be described as a severe case of inflammation in the lungs that occurs suddenly and results in the development of respiratory failure. This is generally associated with various causes like pneumonia,...